The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Aytu BioPharma Inc (NASDAQ: AYTU) was $2.38 for the day, up 4.15% from the previous closing price of $2.29. In other words, the price has increased by $4.15 from its previous closing price. On the day, 0.17 million shares were traded. AYTU stock price reached its highest trading level at $2.45 during the session, while it also had its lowest trading level at $2.27.
Ratios:
Our analysis of AYTU’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on July 01, 2025, initiated with a Buy rating and assigned the stock a target price of $8.
On June 30, 2025, Ascendiant Capital Markets started tracking the stock assigning a Buy rating and target price of $12.
On March 30, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on March 30, 2021, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 09 ’25 when Disbrow Jarrett bought 16,666 shares for $1.50 per share. The transaction valued at 24,999 led to the insider holds 29,462 shares of the business.
Disbrow Joshua R. bought 66,666 shares of AYTU for $99,999 on Jun 09 ’25. The Chief Executive Officer now owns 153,257 shares after completing the transaction at $1.50 per share. On Feb 28 ’25, another insider, Disbrow Joshua R., who serves as the Chief Executive Officer of the company, bought 15,000 shares for $1.30 each. As a result, the insider paid 19,500 and bolstered with 86,591 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AYTU now has a Market Capitalization of 21409930 and an Enterprise Value of 17801136. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.21 while its Price-to-Book (P/B) ratio in mrq is 0.42. Its current Enterprise Value per Revenue stands at 0.218 whereas that against EBITDA is 2.967.
Stock Price History:
The Beta on a monthly basis for AYTU is 0.12, which has changed by -0.1678322 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, AYTU has reached a high of $2.96, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is 36.23%, while the 200-Day Moving Average is calculated to be 42.56%.
Shares Statistics:
AYTU traded an average of 1.43M shares per day over the past three months and 251340 shares per day over the past ten days. A total of 6.17M shares are outstanding, with a floating share count of 5.40M. Insiders hold about 12.52% of the company’s shares, while institutions hold 39.71% stake in the company. Shares short for AYTU as of 1749772800 were 624633 with a Short Ratio of 0.44, compared to 1747267200 on 740353. Therefore, it implies a Short% of Shares Outstanding of 624633 and a Short% of Float of 8.81.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
